| analyte | A substance undergoing analysis, such as glucose or cholesterol.
|
 |
|
|
| assay | A test, examination, or laboratory analysis of a substance.
|
|
|
|
| bleeding time | The time it takes a standardized skin wound to stop bleeding; a test used to evaluate platelet function during clotting.
|
|
|
|
| cannula | A hollow tube used for temporary access to a vein or artery to administer medication or draw blood.
|
|
|
|
| diabetes mellitus | Any of several related endocrine disorders characterized by an elevated level of glucose in the blood, caused by a deficiency of insulin or insulin resistance at the cellular level.
|
|
|
|
| disinfectant | Solution that contains an agent intended to kill or irreversibly inactivate microorganisms.
|
|
|
|
| diurnal variation | Normal changes in laboratory values throughout the day.
|
|
|
|
| gestational diabetes | Elevated blood sugar during pregnancy.
|
|
|
|
| glycolysis | Normal body reaction in which glucose is hydrolyzed or broken down by an enzyme.
|
|
|
|
| hemochromatosis | A disorder of iron metabolism in which too much iron is stored in the body, reaching toxic levels of iron.
|
|
|
|
| keloid | A sharply elevated, irregularly shaped, progressively enlarging scar formed by excessive collagen in the skin during healing.
|
|
|
|
| lipemic | Cloudy serum or plasma following or caused by increased lipids.
|
|
|
|
| Platelet Function Assay (PFA) | Blood test that determines platelet adhesion and aggregation.
|
|
|
|
| polycythemia | A condition in which there is an overproduction of red blood cells.
|
|
|
|
| reference values | Expected values for a laboratory or population, usually established using patients in a basal state.
|
|
|
|
| sphygmomanometer | A device for measuring arterial blood pressure.
|
|
|
|
| therapeutic drug monitoring | Management of an effective drug dose by the physician.
|
|
|
|
| therapeutic medication | Relates to the treatment, remedy, or curing of a disorder through the use of a medicinal substance.
|